Announcement of the result of tender procedure No. 35/2020 – SARCO

OBJECT FOR THE REQUEST: In vitro study package to assess the potential of OATD-01 for Drug-Drug Interactions (DDI)

After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:

Cyprotex Discovery Limited
24 Mereside, Alderley Park
Macclesfield, Cheshire, SK10 4TG
United Kingdom

Total net price of the order execution: 162,938.00 EUR

The Commission recommends the Management Board to perform the order in accordance with the offer submitted by Cyprotex.